Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing-Reference-Cited by-同舟云学术

Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing

Published:2020-04 Issue:4 Volume:16 Page:630-640
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Niznik Joshua D.¹²,Zhao Xinhua²³,He Meiqi³,Aspinall Sherrie L.²³⁴,Hanlon Joseph T.²⁵,Nace David⁵,Thorpe Joshua M.²⁶,Thorpe Carolyn T.²⁶

Affiliation:

1. Department of MedicineDivision of Geriatric MedicineUniversity of North Carolina School of Medicine Chapel Hill North Carolina USA

2. VA Pittsburgh Healthcare SystemCenter for Health Equity Research and PromotionUniversity Drive (151C) Pittsburgh Pennsylvania USA

3. University of Pittsburgh School of Pharmacy Pittsburgh Pennsylvania USA

4. VA Center for Medication Safety Hines Illinois USA

5. Geriatric DivisionKaufmann Medical BuildingUniversity of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

6. University of North Carolina Eshelman School of Pharmacy Chapel Hill North Carolina USA

Funder

Patrick and Catherine Weldon Donaghue Medical Research Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12054

Reference52 articles.

1. Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use

2. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence

3. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta‐analysis;Lanctot KL;CMAJ,2003

4. A Systematic Review of Practice Guidelines and Recommendations for Discontinuation of Cholinesterase Inhibitors in Dementia

5. Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and content of minimum data sets for care homes: A mapping review;2024-06-24

2. Validating claims‐based definitions for deprescribing: Bridging the gap between clinical and administrative data;Pharmacoepidemiology and Drug Safety;2024-03-31

3. Changes in Antidementia Medications upon Admission to the Nursing Home: Who Decides and Why? Results From a National Survey of Nursing Home Administrators;Journal of the American Medical Directors Association;2024-01

4. Antidementia Medication Use in Nursing Home Residents;Journal of Geriatric Psychiatry and Neurology;2023-09-16

5. Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-08-15